bluebird bio Archives - Pharmaphorum

bluebird claims first approval for gene therapy Zynteglo in EU

https://pharmaphorum.com/news/bluebird-claims-first-approval-for-gene-therapy-zynteglo-in-eu/

Gene therapy and market access: the pharmaphorum podcast

https://pharmaphorum.com/podcast/gene-therapy-market-access

Deep Dive: Access and Commercialisation

https://pharmaphorum.com/digital/pharma-access-commercialisation/

bluebird bio gets CHMP nod for gene therapy Zynteglo

https://pharmaphorum.com/news/bluebird-bio-gets-chmp-nod-for-gene-therapy-zynteglo/

Gene addition – a new chapter in treating rare diseases

https://pharmaphorum.com/views-and-analysis/gene-addition-a-new-chapter-in-treating-rare-diseases/

Regeneron forges CAR-T R&D partnership with bluebird bio

https://pharmaphorum.com/news/regeneron-forges-car-t-rd-partnership-with-bluebird-bio/

Spectacular results for bluebird’s gene therapy in thalassemia

https://pharmaphorum.com/news/spectacular-results-for-bluebirds-gene-therapy-in-thalassemia/

Long-term CAR-T data dazzles at ASH

https://pharmaphorum.com/news/long-term-car-t-data-dazzles-ash/

Scotland’s TC BioPharm joins bluebird to develop next-gen CAR-T

https://pharmaphorum.com/news/scotlands-tc-biopharma-joins-bluebird-develop-next-gen-car-t/

Search